The increase in SARS-CoV-2–associated TCR depth in COVID-19 patients compared to previously exposed individuals is more pronounced in the activated CD8+ T-cell subset (fold increase = 5) compared to the increase observed in the nonactivated CD8+ T-cell subset (fold increase = 1.5) (Supplementary Figure 4). The gene discussed is CD8A; the disease is COVID-19.